Targeting cognitive deficits in schizophrenia: a review of the development of a new class of medicines from the perspective of community mental health researchers

Author： Tcheremissine Oleg V   Castro Manuel A   Gardner Dineen R  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.1, 2012-01, pp. : 7-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preattentional and attentional cognitive deficits as targets for treating schizophrenia

By Braff David   Light Gregory  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 75-85

Springer Publishing Company

Access to resources Recommend Favorite

Adrenergic targets for the treatment of cognitive deficits in schizophrenia

By Arnsten Amy  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite

Feasibility of Dissemination of Cognitive Behavioral Therapy to Texas Community Mental Health Centers

By Lopez Molly  

The Journal of Behavioral Health Services & Research, Vol. 38, Iss. 1, 2011-01 ,pp. : 91-104

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Exercise on Physical and Mental Health, and Cognitive and Brain Functions in Schizophrenia: Clinical and Experimental Evidence

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 10, 2015-12 ,pp. : 1244-1254

Bentham Science Publishers

Access to resources Recommend Favorite

New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function

By  

Current Neuropharmacology, Vol. 13, Iss. 6, 2015-12 ,pp. : 793-801

Bentham Science Publishers

Access to resources Recommend Favorite